ScienceDex / Researcher record
Ferdinandos Skoulidis
- UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
- R01 Holder
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,728,438 | 4 | #6,920 |
| 2025 | $1,783,520 | 4 | #7,938 |
| 2026 | $2,082,736 | 4 | #9,986 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20244 records
- FY20254 records
- FY2026 · selected4 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 15708312Search this ID in NIH RePORTER
- ORCID iD
- https://orcid.org/0000-0002-4676-4503Verified identifier for this researcher
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Internal Medicine
- Pathology
FY2026 award records by amount
NIH award records listing Ferdinandos Skoulidis as a PI. Multi-PI records show the full award amount for context.
- 5R01CA279452-03R01Co-investigatorTargeting non-small cell lung cancer cells and the adverse tumor microenvironment with a small-molecule STAT3 inhibitorUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$672Kaward amount
- 1R01CA301423-01A1R01Co-investigatorElucidating roles of the CD24 ligand in early lung cancer development, immune evasion and response to KRAS-targeted therapyUT MD Anderson Cancer Center · Pathology (NIH department code)$669.5Kaward amount
- 5R01CA272570-04R01Contact PIDissecting and targeting mechanisms of genomic instability-triggered immune evasion in RBM10-deficient non-small cell lung cancerUT MD Anderson Cancer Center · Internal Medicine (NIH department code)$370.6Kaward amount
- 5R01CA279194-04R01Contact PIDissecting and targeting tumor-TME crosstalk to forestall acquired KRASG12C inhibitor resistance in NSCLC.UT MD Anderson Cancer Center · Internal Medicine (NIH department code)$370.6Kaward amount
Award organization
Organizations that administered FY2026 awards listing Ferdinandos Skoulidis as a PI.
FY2026 award administered by UT MD Anderson Cancer Center (TX).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUT MD Anderson Cancer Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #6920
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Ferdinandos Skoulidis.